Details

Inhibitory potential of boscalid and abamectin towards acetylcholinesterase and butyrylcholinesterase : computational and in vitro studies
ID Arsić, Biljana (Author), ID Petrović, Stefan (Author), ID Ilić, Budimir S. (Author), ID Vrecl, Milka (Author), ID Trobec, Tomaž (Author), ID Sepčić, Kristina (Author), ID Frangež, Robert (Author), ID Glisić, Sanja (Author), ID Milićević, Jelena S. (Author)

.pdfPDF - Presentation file, Download (905,05 KB)
MD5: 4C073851E2BC3C0055A4D5FCF711B154
URLURL - Source URL, Visit https://www.mdpi.com/1422-0067/26/7/2865 This link opens in a new window

Abstract
The growing demand for agricultural products has led to the misuse of pesticides, resulting in the use of higher concentrations of these substances. This has led to an increase in toxicity imposed on other beneficial organisms and to the bioaccumulation of toxic pesticide concentrations in the bodies of both pests and non-target organisms, as well as in their end users, including humans. In this study, the neurotoxic potential of the commonly used pesticides abamectin (an insecticide) and boscalid (a fungicide) was evaluated. Both in vitro and in silico studies showed that human butyrylcholinesterase is not a target for abamectins B1A and B1B. Boscalid showed a modest Glide score (−28.8 kJ/mol) and a considerably higher IC50 (308.8 µM) against human butyrylcholinesterase than the approved inhibitor (2-((1-(benzenesulfonyl)-1H-indol-4-yl)oxy)ethyl)(benzyl)amine (IC50 = 0.473 µM). However, due to its non-mutagenicity and low toxicity, structural analogues of boscalid might be considered as candidates for the symptomatic treatment of Alzheimer’s disease. Molecular dynamics simulations over 100 ns confirmed the stability of boscalid within the active site of butyrylcholinesterase, where it maintained key interactions with catalytic residues such as Trp82 and His438. These findings highlight its potential as a starting point for structure-based drug design strategies aimed at optimizing cholinesterase inhibitors with improved pharmacokinetic properties. According to absorption, distribution, metabolism, elimination, and toxicity studies, boscalid is orally active, which cannot be attributed to abamectins B1A and B1B.

Language:English
Keywords:cholinesterases, enzyme inhibition, pesticides, electron-ion interaction potential, molecular docking, molecular dynamics simulations
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:VF - Veterinary Faculty
BF - Biotechnical Faculty
Publication status:Published
Publication version:Version of Record
Year:2025
Number of pages:11 str.
Numbering:Vol. 26, iss. 7, art. 2865
PID:20.500.12556/RUL-168084 This link opens in a new window
UDC:616-092
ISSN on article:1422-0067
DOI:10.3390/ijms26072865 This link opens in a new window
COBISS.SI-ID:230159619 This link opens in a new window
Publication date in RUL:28.03.2025
Views:380
Downloads:109
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:International journal of molecular sciences
Shortened title:Int. j. mol. sci.
Publisher:MDPI
ISSN:1422-0067
COBISS.SI-ID:2779162 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Projects

Funder:MESTD - Ministry of Education, Science and Technological Development of Republic of Serbia
Project number:337-00-21/2020-09/19

Funder:MESTD - Ministry of Education, Science and Technological Development of Republic of Serbia
Project number:451-03-47/2023-01/200124

Funder:MESTD - Ministry of Education, Science and Technological Development of Republic of Serbia
Project number:451-03-66/2024-03/200124

Funder:MESTD - Ministry of Education, Science and Technological Development of Republic of Serbia
Project number:45-03-136/2025-03/200124

Funder:MESTD - Ministry of Education, Science and Technological Development of Republic of Serbia
Project number:451-03-65/2024-03/200113

Funder:MESTD - Ministry of Education, Science and Technological Development of Republic of Serbia
Project number:451-03-137/2025-03/200113

Funder:MESTD - Ministry of Education, Science and Technological Development of Republic of Serbia
Project number:451-03-47/2023-01/200017

Funder:MESTD - Ministry of Education, Science and Technological Development of Republic of Serbia
Project number:451-03-66/2024-03/200017

Funder:MESTD - Ministry of Education, Science and Technological Development of Republic of Serbia
Project number:451-03-136/2025-03/200017

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P4-0053
Name:Endokrini, imunski in encimski odzivi pri zdravih in bolnih živalih

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0207
Name:Toksini in biomembrane

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back